Professional and Reliable IHC Raw Antibody Solutions for Prostate Pathology
Prostate pathology frequently requires differentiation between carcinoma and benign hyperplasia. AREX provides high-quality IHC raw antibodies supporting detection of epithelial and basal cell markers to optimize diagnostic, grading, and prognostic assessment solutions for prostate cancer.
Core Advantages:
High specificity and low background suited to the fine glandular staining environment of prostate tissue
Good sensitivity meeting needs across varying lesion severities
Excellent batch-to-batch consistency for large-scale OEM supply
AREX prostate pathology raw antibodies integrate seamlessly with our
ARExVisual® micropolymer detection system and
Ancillaries supporting reagents to deliver a complete IHC solution.
Contact us to request catalogs, sample testing, or technical consultation.
Product List
